MYCOBUTIN- rifabutin capsule Соединенные Штаты - английский - NLM (National Library of Medicine)

mycobutin- rifabutin capsule

department of state health services, pharmacy branch - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg - mycobutin capsules are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. mycobutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

PRIFTIN- rifapentine tablet, film coated Соединенные Штаты - английский - NLM (National Library of Medicine)

priftin- rifapentine tablet, film coated

sanofi-aventis u.s. llc - rifapentine (unii: xjm390a33u) (rifapentine - unii:xjm390a33u) - rifapentine 150 mg - priftin® (rifapentine) is indicated in adults and children 12 years and older for the treatment of active pulmonary tuberculosis (tb) caused by mycobacterium tuberculosis . priftin must always be used in combination with one or more antituberculosis (anti-tb) drugs to which the isolate is susceptible [see dosage and administration (2.1) and clinical studies (14.1)] . limitations of use do not use priftin monotherapy in either the initial or the continuation phases of active antituberculous treatment. priftin should not be used once weekly in the continuation phase regimen in combination with isoniazid (inh) in hiv-infected patients with active pulmonary tuberculosis because of a higher rate of failure and/or relapse with rifampin (rif)-resistant organisms [see warnings and precautions (5.4) and clinical studies (14.1)] . priftin has not been studied as part of the initial phase treatment regimen in hiv-infected patients with active pulmonary tuberculosis. priftin is indicated in adults and children 2 years